We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO Latin America Conference
September 4-5, 2018
BIO Investor Forum
October 17-18, 2018
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
October 17 - 18, 2018 | San Francisco, California
Dr. Melcher joined Xyphos in April 2018 to lead the business and corporate development activities. Previously he served in business development roles at Calico, Johnson & Johnson Innovation, Varian Medical Systems, and Saegis Pharmaceuticals. Earlier in his career, he led scientific teams and was co-founder of AGY Therapeutics and EnVivo Pharmaceuticals. He earned his MSc equivalent degree from the University of Hannover, and a PhD equivalent degree from the Center for Molecular Biology (ZMBH) in Heidelberg. Subsequently, he conducted postdoctoral research at ZMBH and the University of California, San Francisco
This speaker's sessions: